|
SLMO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.467600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.965950E-01 |
| Normal-vs-Stage2 |
8.730200E-01 |
| Normal-vs-Stage3 |
1.669810E-01 |
| Normal-vs-Stage4 |
4.967000E-01 |
| Stage1-vs-Stage2 |
6.011000E-01 |
| Stage1-vs-Stage3 |
1.847740E-02 |
| Stage1-vs-Stage4 |
2.375000E-01 |
| Stage2-vs-Stage3 |
2.376200E-01 |
| Stage2-vs-Stage4 |
4.781000E-01 |
| Stage3-vs-Stage4 |
7.449800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.111200E-01 |
| Normal-vs-AfricanAmerican |
2.892800E-01 |
| Normal-vs-Asian |
8.206400E-01 |
| Caucasian-vs-AfricanAmerican |
4.746800E-01 |
| Caucasian-vs-Asian |
9.892200E-01 |
| AfricanAmerican-vs-Asian |
7.810000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.867800E-01 |
| Normal-vs-Female |
3.524800E-01 |
| Male-vs-Female |
6.126000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.738400E-01 |
| Normal-vs-Extreme_Weight |
1.123790E-01 |
| Normal-vs-Obese |
6.363000E-01 |
| Normal-vs-Extreme_Obese |
6.080600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.094800E-01 |
| Normal_Weight-vs-Obese |
2.600000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.295800E-01 |
| Extreme_Weight-vs-Obese |
8.167700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.080600E-01 |
| Obese-vs-Extreme_Obese |
4.685000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.494600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.725200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.711970E-01 |
| Normal-vs-Age(81-100Yrs) |
6.760000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.782400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.959600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.578250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.108200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.080300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.882500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.106100E-02 |
| Normal-VS-Type2 PRCC |
7.015800E-01 |
| Normal-VS-KIRP CIMP |
2.015000E-01 |
| Normal-VS-Unclassified PRCC |
2.628200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.512800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.611830E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.350410E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.297040E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.031400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.932800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.124100E-02 |
| Normal-vs-N1 |
4.616400E-02 |
| Normal-vs-N2 |
5.590400E-01 |
| N0-vs-N1 |
2.375600E-03 |
| N0-vs-N2 |
8.926400E-01 |
| N1-vs-N2 |
1.749010E-01 |
|
|
